| |
| |
|
| Insider
Information: |
Larson Tina Marriott |
| Relationship: |
President and COO |
| City: |
Salt Lake City |
| State: |
UT |
| |
|
| Insider
Summary: |
|
|
|
|
Companies Owned : |
1 |
|
| Direct
Shares |
543,231 |
|
|
Indirect Shares
|
0 |
|
|
| Direct
Value |
$4,693,516 |
|
|
|
Indirect Value
|
$0 |
|
|
| Total
Shares |
543,231 |
|
|
| Total
Value |
$4,693,516 |
|
|
|
|
|
|
|
|
Historical
Performance :
Based on 6 Month Return Percentages |
Buys
|
Sells
|
|
Total
Filings :
|
0
|
0
|
|
Stock
price went up :
|
|
|
| Stock
price went down : |
|
|
| |
|
|
|
Gain/Loss Ratio : |
0.0
|
0.0
|
| Percentage
Gain/Loss : |
0.0%
|
0.0%
|
| |
|
|
|
|
|
Holdings
:
| Menu |
Company Name |
Ticker |
Relation |
Direct Date |
Direct Shares |
Indirect Date |
Indirect Shares |
Total Value Sold  |
 |
Recursion Pharmaceuticals, Inc. |
RXRX |
President and COO |
2024-04-25 |
543,231 |
|
0 |
Premium* |
|
|
|
|
|
|
|
|
|
|
|
Records found :
25 |
Free Registration Required For Full Results. Limit: 25
|
 |
Download |
Page 1 of 1
|
| Ticker |
Company Name |
Relation |
Off-Dir-10% |
Trans. Date |
Form |
Action |
Price |
Mkt Value |
D/I |
Shares |
Holdings |
Rank
|
|
|
| 3m +/- |
|
|
Form |
| RXRX |
Recursion Pharmaceuticals... |
President and COO |
• – – |
2024-04-25 |
4 |
AS |
$7.67 |
$23,021 |
D/D |
(3,000) |
543,231 |
0 |
% |
|
| RXRX |
Recursion Pharmaceuticals... |
President and COO |
• – – |
2024-04-25 |
4 |
OE |
$1.06 |
$3,180 |
D/D |
3,000 |
546,231 |
0 |
- |
|
| RXRX |
Recursion Pharmaceuticals... |
President and COO |
• – – |
2024-03-21 |
4 |
AS |
$10.70 |
$85,980 |
D/D |
(8,000) |
639,982 |
0 |
% |
|
| RXRX |
Recursion Pharmaceuticals... |
President and COO |
• – – |
2024-03-21 |
4 |
OE |
$1.06 |
$8,480 |
D/D |
8,000 |
647,982 |
0 |
- |
|
| RXRX |
Recursion Pharmaceuticals... |
President and COO |
• – – |
2024-02-22 |
4 |
AS |
$14.90 |
$119,160 |
D/D |
(8,000) |
639,982 |
0 |
% |
|
| RXRX |
Recursion Pharmaceuticals... |
President and COO |
• – – |
2024-02-22 |
4 |
OE |
$1.06 |
$8,480 |
D/D |
8,000 |
647,982 |
0 |
- |
|
| RXRX |
Recursion Pharmaceuticals... |
President and COO |
• – – |
2024-02-15 |
4 |
D |
$12.43 |
$66,861 |
D/D |
(5,379) |
639,982 |
0 |
- |
|
| RXRX |
Recursion Pharmaceuticals... |
President and COO |
• – – |
2024-02-09 |
4 |
A |
$0.00 |
$0 |
D/D |
233,613 |
648,161 |
0 |
- |
|
| RXRX |
Recursion Pharmaceuticals... |
President and COO |
• – – |
2024-02-09 |
4 |
D |
$10.09 |
$28,252 |
D/D |
(2,800) |
645,361 |
0 |
- |
|
| RXRX |
Recursion Pharmaceuticals... |
President and COO |
• – – |
2024-01-25 |
4 |
AS |
$10.35 |
$82,762 |
D/D |
(8,000) |
414,548 |
0 |
% |
|
| RXRX |
Recursion Pharmaceuticals... |
President and COO |
• – – |
2024-01-25 |
4 |
OE |
$1.06 |
$8,480 |
D/D |
8,000 |
422,584 |
0 |
- |
|
| RXRX |
Recursion Pharmaceuticals... |
President and COO |
• – – |
2023-12-28 |
4 |
AS |
$10.58 |
$84,654 |
D/D |
(8,000) |
414,548 |
0 |
% |
|
| RXRX |
Recursion Pharmaceuticals... |
President and COO |
• – – |
2023-12-28 |
4 |
OE |
$1.06 |
$8,480 |
D/D |
8,000 |
422,548 |
0 |
- |
|
| RXRX |
Recursion Pharmaceuticals... |
President and COO |
• – – |
2023-11-16 |
4 |
OE |
$1.06 |
$3,180 |
D/D |
3,000 |
416,404 |
0 |
- |
|
| RXRX |
Recursion Pharmaceuticals... |
President and COO |
• – – |
2023-11-16 |
4 |
AS |
$6.76 |
$20,280 |
D/D |
(3,000) |
413,404 |
0 |
% |
|
| RXRX |
Recursion Pharmaceuticals... |
President and COO |
• – – |
2023-11-15 |
4 |
D |
$7.18 |
$38,614 |
D/D |
(5,378) |
413,404 |
0 |
- |
|
| RXRX |
Recursion Pharmaceuticals... |
President and COO |
• – – |
2023-10-26 |
4 |
AS |
$5.63 |
$16,885 |
D/D |
(3,000) |
418,782 |
0 |
% |
|
| RXRX |
Recursion Pharmaceuticals... |
President and COO |
• – – |
2023-10-26 |
4 |
OE |
$1.06 |
$3,180 |
D/D |
3,000 |
421,782 |
0 |
- |
|
| RXRX |
Recursion Pharmaceuticals... |
President and COO |
• – – |
2023-09-28 |
4 |
AS |
$7.72 |
$23,159 |
D/D |
(3,000) |
418,782 |
0 |
% |
|
| RXRX |
Recursion Pharmaceuticals... |
President and COO |
• – – |
2023-09-28 |
4 |
OE |
$1.06 |
$3,180 |
D/D |
3,000 |
421,782 |
0 |
- |
|
| RXRX |
Recursion Pharmaceuticals... |
President and COO |
• – – |
2023-08-24 |
4 |
OE |
$1.06 |
$3,180 |
D/D |
3,000 |
421,782 |
0 |
- |
|
| RXRX |
Recursion Pharmaceuticals... |
President and COO |
• – – |
2023-08-24 |
4 |
AS |
$8.64 |
$25,968 |
D/D |
(3,000) |
418,782 |
0 |
% |
|
| RXRX |
Recursion Pharmaceuticals... |
President and COO |
• – – |
2023-08-15 |
4 |
D |
$9.18 |
$49,370 |
D/D |
(5,378) |
418,782 |
0 |
- |
|
| RXRX |
Recursion Pharmaceuticals... |
President and COO |
• – – |
2023-07-27 |
4 |
AS |
$13.12 |
$108,994 |
D/D |
(8,000) |
424,160 |
0 |
% |
|
| RXRX |
Recursion Pharmaceuticals... |
President and COO |
• – – |
2023-07-27 |
4 |
OE |
$1.06 |
$8,480 |
D/D |
8,000 |
432,160 |
0 |
- |
|
25 Records found
|
1
|
Page 1 of 1 |
| |
Free Registration Required For Full Results. Limit: 25
|
|
| |
Transaction Code Key: |
Ownership Code Key |
| |
B |
- Buy |
AB |
- Automatic Buy |
D |
- Direct Ownership |
| |
S |
- Sell |
AS |
- Automatic Sell |
I |
- Indirect Ownership |
|
OE |
- Options Exercised |
A |
- Aquired |
| |
IO |
- Initital Ownership |
D |
- Disposed |
| |
|
|
|
|
|
